| Automated methods for cell type annotation on scRNA-seq data G Pasquini, JE Rojo Arias, P Schäfer, V Busskamp Computational and Structural Biotechnology Journal 19, 961-969, 2021 | 156 | 2021 |
| A comprehensive library of human transcription factors for cell fate engineering AHM Ng*, P Khoshakhlagh*, JE Rojo Arias, G Pasquini, K Wang, ... Nature Biotechnology 39 (4), 510-519, 2021 | 137 | 2021 |
| Retinal miRNA functions in health and disease M Zuzic, JE Rojo Arias, SG Wohl, V Busskamp Genes 10 (5), 377, 2019 | 65 | 2019 |
| Microfluidics for Neuronal cell and circuit engineering R Habibey*, JE Rojo Arias*, J Striebel, V Busskamp Chemical Reviews 122 (18), 14842-14880, 2022 | 35 | 2022 |
| Challenges in microRNAs’ targetome prediction and validation JE Rojo Arias, V Busskamp Neural regeneration research 14 (10), 1672, 2019 | 22 | 2019 |
| VEGF‐Trap is a potent modulator of vasoregenerative responses and protects dopaminergic amacrine network integrity in degenerative ischemic neovascular retinopathy JE Rojo Arias, M Economopoulou, DA Juarez Lopez, A Kurzbach, ... Journal of neurochemistry 153 (3), 390-412, 2020 | 12 | 2020 |
| VEGF-trap modulates retinal inflammation in the murine oxygen-induced retinopathy (OIR) model JE Rojo Arias, VE Englmaier, J Jászai Biomedicines 10 (2), 201, 2022 | 8 | 2022 |
| Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap) JE Rojo Arias, J Jászai Scientific Reports 11 (1), 1-20, 2021 | 5 | 2021 |
| 微小 RNA 靶向集合预测和验证面临的挑战 JE Rojo Arias, V Busskamp 中国神经再生研究 (英文版) 14 (10), 1672, 2019 | | 2019 |
| Exploring novel neurogenic transcription factors in human induced pluripotent stem cells A Sidorenkova, JER Arias, V Busskamp | | |
